Exagen (XGN) Operating Margin (2018 - 2026)

Exagen (XGN) has 9 years of Operating Margin data on file, last reported at 19.73% in Q1 2026.

• Quarterly Operating Margin rose 199.0% year-over-year to 19.73% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 20.65% (up 403.0% YoY) and the FY2025 annual result came in at 21.13%, up 337.0% from the prior year.
• Operating Margin improved to 19.73% in Q1 2026, from 29.91% in the prior quarter.
• In the past five years, Operating Margin ranged from a high of 15.29% in Q2 2025 to a low of 184.91% in Q2 2022.
• A 5-year average of 48.66% and a median of 34.77% in 2023 frame the typical range for Operating Margin.
• Annual changes were most pronounced in 2022 — Operating Margin plunged 13995 bps — and 2023, when it soared 15014 bps.
• Tracing XGN's Operating Margin over 5 years: stood at 112.88% in 2022, then surged by 67 bps to 37.39% in 2023, then jumped by 34 bps to 24.77% in 2024, then retreated by 21 bps to 29.91% in 2025, then jumped by 34 bps to 19.73% in 2026.
• The last three Operating Margin figures came in at 19.73% (Q1 2026), 29.91% (Q4 2025), and 17.98% (Q3 2025), per Business Quant data.